2025 SPEAKERS
Anton Becker, MD, PhD
Kathryn Beckermann, MD, PhD
Kathryn Beckermann, MD, PhD
Assistant Professor Department of Radiology at NYU Grossman School of Medicine
New York, NY
Kathryn Beckermann, MD, PhD
Kathryn Beckermann, MD, PhD
Kathryn Beckermann, MD, PhD
Assistant Professor of Medicine, Division of Hematology and Oncology, Department of Medicine Vanderbilt University Medical Center
Nashville, TN
Steven Campbell, MD, PhD
Kathryn Beckermann, MD, PhD
Jason Efstathiou, MD, DPhil
Professor of Surgery, Residency Program Director and a member of the Section of Urologic Oncology in the Glickman Urological and Kidney Institute at Cleveland Clinic
Cleveland, OH
Jason Efstathiou, MD, DPhil
Kathryn Beckermann, MD, PhD
Jason Efstathiou, MD, DPhil
Professor of Radiation Oncology at Harvard Medical School
Vice-Chair of Faculty & Academic Affairs and Director of the Genitourinary (GU) Division Department of Radiation Oncology and Clinical Co-Director of The Claire and John Bertucci Center for GU Cancers at Massachusetts General Hospital, Boston, MA
Gopa Iyer, MD
Alexandre Zlotta MD, PHD, FRCSC
Matthew Milowsky, MD, FASCO
Section Head, Bladder Cancer
Genitourinary Oncology, Early Drug Development
Memorial Sloan Kettering Cancer Center, New York, NY
Matthew Milowsky, MD, FASCO
Alexandre Zlotta MD, PHD, FRCSC
Matthew Milowsky, MD, FASCO
George Gabriel and Frances Gable Villere Distinguished Professor of Medicine
Vice Chief for Research & Education
Section Chief, Genitourinary Oncology
Judd Moul, MD
Alexandre Zlotta MD, PHD, FRCSC
Alexandre Zlotta MD, PHD, FRCSC
James H. Semans, M.D. Distinguished Professor of Urologic Surgery, in the School of Medicine, Urology
Professor of Urology
Professor in Anesthesiology Anesthesiology
Duke University Medical Center, Durham, NC
Alexandre Zlotta MD, PHD, FRCSC
Alexandre Zlotta MD, PHD, FRCSC
Alexandre Zlotta MD, PHD, FRCSC
Professor, Department of Surgery (Urology), University of Toronto
Director of Uro-Oncology, Mount Sinai Hospital
Surgeon, Princess Margaret Cancer Centre, University Health Network
Director, Uro-Oncology Fellowship Program, University of Toronto
Director of the Bladder Cancer Research Program, Toronto, Ontario, Canada
DRAFT AGENDA
FRIDAY, OCTOBER 24, 2025
8:00 – 10:00am Registration/Exhibit Space Open
10:00 -10:45am Contemporary Surgical Management of Renal Cell Carcinoma
Steven Campbell, MD, PhD – Cleveland Clinic
10:45 – 11:00 am Questions & Answers
11:00 – 11:45 am Systemic Therapy for Renal Cell Carcinoma: Immunotherapy vs Immunotherapy & TKIs
Kathryn Beckermann, MD, PhD – Vanderbilt
11:45 – 12:00 pm Questions & Answers
12:00 – 1:00 pm Lunch (sponsored with speaker non-CME)
1:00 – 1:45 pm Management of Muscle-Invasive Bladder Cancer
Matthew Milowsky, MD, FASCO
1:45 – 2:00 pm Questions & Answers
2:00 – 2:45 pm Update on Diagnosis, Risk Assessment and Surgical Management of Localized Prostate Cancer 2024
Judd Moul, MD – Duke
2:45 – 3:00 pm Questions & Answers
3:00 – 3:45 pm Role of Next-Generation Imaging in Treatment for Advanced Prostate Cancer
Anton Becker, MD, PhD – NYU Langone
3:45 – 4:00 pm Questions & Answers
SATURDAY, OCTOBER 25, 2025
8:00 – 9:00 am Breakfast (sponsored with speaker non-CME)
9:00 – 9:45 am High Risk Locally Advanced Oligometastatic Disease
Jason Efstathiou, MD, DPhil – Harvard
9:45 – 10:00 am Questions & Answers
10:00 – 10:45 am Metastatic Bladder Cancer: Immunologic & Targeted Approaches
Gopa Iyer, MD – MSKCC
10:45 – 11:00 am Questions & Answers
11:00 – 11:45 am Trimodality Therapy in Bladder Cancer
Alex Zlotta, MD, PHD, FRCSC– Mt Sinai
11:45 – 12:00 pm Questions & Answers
12:00 – 1:00 pm Lunch (sponsored with speaker non-CME)
1:00 – 1:45 pm Systemic Treatment for Prostate Cancer
TBD
1:45 – 2:00 pm Questions & Answers
2:00 – 2:45 pm Proton vs Photon Therapy in Prostate Cancer
Jason Efstathiou, MD, DPhil – Harvard
2:45 – 3:00 pm Questions & Answers